VIREO GROWTH INC

Vireo Growth’s merger with Eaze and acquisition of Agribusiness Holdings boost its medical‑cannabis reach, while a share‑consolidation plan sharpens shareholder value and financial strength.

Vireo Growth Inc. expands nationwide, adding 160 dispensaries and key retail assets in Colorado, California, Florida and more—boosting cannabis retail, production, and horticultural capabilities in a single move.

Vireo Growth Inc., a pharmaceutical company operating in the cannabis industry, faces challenges due to market fluctuations, financial difficulties, and regulatory complexities, which may impact its future performance and investor confidence.

Vireo Growth Inc. reported a 1.9% year-over-year revenue increase to $24.5 million in Q1 2025, with the company anticipating merger transactions to bolster profitability in the second quarter.